Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of ERMP1 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Ermp1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ERMP1 mRNA | CTD | PMID:22206623 | 1,3,5-trinitro-1,3,5-triazinane | decreases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | cyclonite results in decreased expression of ERMP1 mRNA | CTD | PMID:25559034 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ERMP1 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ERMP1 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ERMP1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ERMP1 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ERMP1 mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ermp1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ERMP1 mRNA | CTD | PMID:21570461 | 2,6-dinitrotoluene | affects expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of ERMP1 mRNA | CTD | PMID:21346803 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Ermp1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ERMP1 mRNA | CTD | PMID:26251327 | 3,4-methylenedioxymethamphetamine | increases methylation | ISO | Ermp1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of ERMP1 promoter | CTD | PMID:26251327 | 5-aza-2'-deoxycytidine | affects expression | EXP | | 6480464 | Decitabine affects the expression of ERMP1 mRNA | CTD | PMID:23300844 | aflatoxin B1 | decreases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of ERMP1 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Tretinoin results in increased expression of ERMP1 mRNA | CTD | PMID:16788091 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ERMP1 mRNA | CTD | PMID:16249480 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ERMP1 mRNA | CTD | PMID:33212167 | arsane | affects expression | EXP | | 6480464 | Arsenic affects the expression of ERMP1 mRNA | CTD | PMID:18414638 | arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of ERMP1 mRNA | CTD | PMID:18414638 | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ERMP1 mRNA] | CTD | PMID:32406909 | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of ERMP1 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of ERMP1 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ERMP1 protein | CTD | PMID:32717239 | beta-hexachlorocyclohexane | decreases expression | ISO | Ermp1 (Mus musculus) | 6480464 | beta-hexachlorocyclohexane results in decreased expression of ERMP1 mRNA | CTD | PMID:25270620 | bisphenol A | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ERMP1 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ERMP1 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ERMP1 mRNA | CTD | PMID:30816183 more ... | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ERMP1 mRNA | CTD | PMID:35301059 | cadmium dichloride | decreases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of ERMP1 mRNA | CTD | PMID:33453195 | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ERMP1 mRNA | CTD | PMID:35301059 | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of ERMP1 mRNA | CTD | PMID:16002434 and PMID:26485663 | carbon nanotube | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | choline | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | [Dietary Fats co-treated with Choline deficiency] results in increased expression of ERMP1 mRNA and PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of ERMP1 mRNA] | CTD | PMID:29246445 | cisplatin | affects expression | EXP | | 6480464 | Cisplatin affects the expression of ERMP1 mRNA | CTD | PMID:23300844 | clofibrate | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ERMP1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ERMP1 mRNA] | CTD | PMID:17585979 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ERMP1 mRNA | CTD | PMID:19549813 | crocidolite asbestos | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of ERMP1 mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ERMP1 mRNA | CTD | PMID:20106945 more ... | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of ERMP1 mRNA | CTD | PMID:35967413 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | epoxiconazole | decreases expression | ISO | Ermp1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ERMP1 mRNA | CTD | PMID:35436446 | finasteride | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of ERMP1 mRNA | CTD | PMID:24136188 | flutamide | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of ERMP1 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of ERMP1 mRNA] | CTD | PMID:22206623 | folic acid | decreases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ERMP1 mRNA | CTD | PMID:25629700 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of ERMP1 protein | CTD | PMID:37730182 | gentamycin | decreases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ERMP1 mRNA | CTD | PMID:22061828 | glyphosate | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Glyphosate results in increased expression of ERMP1 mRNA | CTD | PMID:35897073 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of ERMP1 protein | CTD | PMID:32959892 | ketamine | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Ketamine results in increased expression of ERMP1 mRNA | CTD | PMID:20080153 | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of ERMP1 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of ERMP1 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ERMP1 mRNA | CTD | PMID:23179753 and PMID:27188386 | nefazodone | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of ERMP1 mRNA | CTD | PMID:24136188 | Nivalenol | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | nivalenol results in increased expression of ERMP1 mRNA | CTD | PMID:35016910 | p-toluidine | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | 4-toluidine results in increased expression of ERMP1 mRNA | CTD | PMID:27638505 | paracetamol | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ERMP1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ERMP1 mRNA] | CTD | PMID:17585979 | paraquat | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Paraquat results in increased expression of ERMP1 mRNA | CTD | PMID:21371552 | pentachlorophenol | affects expression | ISO | Ermp1 (Mus musculus) | 6480464 | Pentachlorophenol affects the expression of ERMP1 mRNA | CTD | PMID:23892564 | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ERMP1 mRNA | CTD | PMID:25812627 | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ERMP1 mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ERMP1 mRNA | CTD | PMID:25812627 | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of ERMP1 mRNA and perfluorooctanoic acid results in decreased expression of ERMP1 protein | CTD | PMID:25812627 and PMID:26879310 | phenobarbital | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of ERMP1 mRNA | CTD | PMID:19482888 | phenobarbital | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ERMP1 mRNA] | CTD | PMID:19482888 | pirinixic acid | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ERMP1 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ERMP1 mRNA | CTD | PMID:17426115 more ... | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of ERMP1 mRNA | CTD | PMID:22714537 | resveratrol | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | resveratrol results in increased expression of ERMP1 protein | CTD | PMID:25505154 | rimonabant | multiple interactions | ISO | Ermp1 (Mus musculus) | 6480464 | Rimonabant inhibits the reaction [Dietary Fats results in increased expression of ERMP1 mRNA] | CTD | PMID:19030233 | rotenone | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of ERMP1 protein | CTD | PMID:35544339 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of ERMP1 mRNA | CTD | PMID:25895662 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of ERMP1 mRNA | CTD | PMID:31533062 | T-2 toxin | decreases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | T-2 Toxin results in decreased expression of ERMP1 mRNA | CTD | PMID:26141394 | tetrachloromethane | decreases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of ERMP1 mRNA | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of ERMP1 mRNA | CTD | PMID:30723492 | trichloroethene | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of ERMP1 mRNA | CTD | PMID:19448997 | trichloroethene | increases methylation | ISO | Ermp1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of ERMP1 gene | CTD | PMID:27618143 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of ERMP1 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERMP1 mRNA | CTD | PMID:27188386 | Triptolide | increases expression | ISO | Ermp1 (Rattus norvegicus) | 6480464 | triptolide results in increased expression of ERMP1 protein | CTD | PMID:32519852 | troglitazone | increases expression | ISO | Ermp1 (Mus musculus) | 6480464 | troglitazone results in increased expression of ERMP1 mRNA | CTD | PMID:28973697 | trovafloxacin | decreases expression | ISO | Ermp1 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of ERMP1 mRNA | CTD | PMID:35537566 | ursodeoxycholic acid | affects expression | EXP | | 6480464 | Ursodeoxycholic Acid affects the expression of ERMP1 mRNA | CTD | PMID:18422935 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ERMP1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ERMP1 mRNA | CTD | PMID:19101580 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERMP1 mRNA | CTD | PMID:27188386 | |